NCT05124496View on ClinicalTrials.gov

Validation of HyperDetector for SARS-CoV-2

SuspendedOBSERVATIONAL

Enrollment

10,000

Participants

Timeline

Start Date

December 11, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions

SARS-COV2 Infection

Interventions

DEVICE

Screening Device

Screening device comparing Rt-PCR positive and negative results to HyperDetector results

Trial Locations (1)

22314

HyperSpectral APD, LLC, Alexandria

Sponsors

Lead Sponsor

HyperSpectral APD

All Listed Sponsors

lead

HyperSpectral APD

INDUSTRY

NCT05124496 - Validation of HyperDetector for SARS-CoV-2 | Biotech Hunter | Biotech Hunter